Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT05824234
Recruiting Not applicable

Implementation of REFOCUS Training Program in Mental Health Services

NCT05824234 · tracked via the Priya Life Science France tracker
Sponsor
Hôpital le Vinatier
Phase
Not applicable
Started
2023-06-19
Last updated
2026-06-12

Condition(s) studied

Mental Disorders

Investigational drug(s) / intervention(s)

Implementation of a training centered around the notions of recovery with mental health services first yearImplementation of a training centered around the notions of recovery with mental health services second year

Implementation of a training centered around the notions of recovery with mental health services first year: Stepped wedge design so same procedure for both arms Stepped-wedge design with randomization stratified by cluster (training over the 1st or 2nd year) according to professional practice (intra-hospital, CMP / CATTP, day hospital, Psychosocial Rehabilitation Center, mobile team, medical sector) social) of the teams formed by the 18 centers participating in the study

Implementation of a training centered around the notions of recovery with mental health services second year: Stepped wedge design so same procedure for both arms Stepped-wedge design with randomization stratified by cluster (training over the 1st or 2nd year) according to professional practice (intra-hospital, CMP / CATTP, day hospital, Psychosocial Rehabilitation Center, mobile team, medical sector) social) of the teams formed by the 18 centers participating in the study

Study summary

Training of mental health service teams in the orientation of care towards recovery through a 3-day training course: REFOCUS. This training aims to orient care towards recovery. Following this training, evaluation of the effectiveness of the implementation of REFOCUS training in mental health services.

Eligibility

Sex
ALL
Min age
15 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Age from 15 to 65 years old. * Diagnosis of schizophrenia, schizoaffective disorder, schizotypal disorder and schizophreniform disorder or bipolar disorder, borderline personality disorder, disabling anxiety or depressive disorder (DSM-V criteria; APA, 2013). * Patients cared for by the team or unit benefiting from REFOCUS training * French mother tongue. * Patient affiliated or entitled to a social security scheme * Patient having received information about the study and having confirmed their participation in the study by signing the consent form * For minors (\< 18 years), information given to holders of parental authority and signature of consent. * For patients under curatorship, form signed by the patient and information given to the curator Exclusion Criteria: * Age less than 15 years old * Patients under guardianship * Presence of an associated intellectual disability * Neurological disorders of vascular, infectious or neurodegenerative origin. * Taking somatic drugs with a cerebral or psychic impact (eg corticosteroids).

Primary outcome measure(s)

  • Questionnaire about the Process of Recovery QPR Intra- and inter-group comparison in users with severe psychiatric disorders — Two years
    Intra- and inter-group comparison of the score on the self-assessment scale of the stage of recovery (Questionnaire about the Process of Recovery; QPR) in users with severe psychiatric disorders The QPR has 15 items each scored on a 4-point scale (0= disagree strongly, 1=disagree, 2=neither agree nor disagree, 3=agree, 4=agree strongly). Higher scores are indicative of recovery. However, those involved in developing this measure suggest that scores should not only be added to give total scores, but the QPR should be used as described above e.g. as a tool for considering personal goals for recovery, health and wellbeing.

Trial sites (1)

FacilityCityRegionStatus
centre de réhabilitation - Hôpital le Vinatier Lyon Rhône Recruiting

More Hôpital le Vinatier trials in France

REALITY MONITORING AND DOPAMINE Recruiting
Impulsivity With Borderline Personality Disorder/tMS Recruiting
Effectiveness of a Parent-mediated Intervention With PACT on Children With ASD Recruiting
Evaluation of the Safety Plan to Prevent Suicidal Reiteration Recruiting
Motor Imagery in Aphantasia Recruiting

Other trials for the same condition

French Observatory of ElectroConvulsive Therapy (ECT) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05824234 on ClinicalTrials.gov ↗ ← All trials in France